This inventor holds 1 USPTO granted patent. Top assignee: Delta Biotechnology Limited. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Hendrik Van Urk: Innovator in High Purity Albumin Production
Introduction
Hendrik Van Urk is a notable inventor based in Radcliffe-on-Trent, GB. He has made significant contributions to the field of biotechnology, particularly in the production of high purity albumin. His innovative approach has the potential to impact various applications in medicine and research.
Latest Patents
Hendrik holds a patent for a process titled "High purity albumin and method of producing." This patent describes a method for preparing albumin that is essentially free of colorants, metal ions, human proteins, fragments of albumin, polymers or aggregates of albumin, and viruses. The process also ensures that the albumin is relatively non-glycated, high in free thiol, and maintains an intact C-terminus. The method involves passing albumin, preferably expressed and secreted by transformed yeast, through two chromatography purifications, ultrafiltering the product, and undergoing two further chromatography steps followed by another ultrafiltration.
Career Highlights
Hendrik is associated with Delta Biotechnology Limited, where he applies his expertise in biotechnology to develop innovative solutions. His work in the field has led to advancements in the production of high-quality albumin, which is crucial for various therapeutic applications.
Collaborations
Hendrik has collaborated with notable colleagues, including Andrew Robert Goodey and Darrell Sleep. These collaborations have fostered a productive environment for innovation and research within the company.
Conclusion
Hendrik Van Urk's contributions to the field of biotechnology, particularly through his patent for high purity albumin production, highlight his role as an innovator. His work continues to influence advancements in medical and research applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile